Markus KLEMKE
2Patents
0h-index
3Co-inventors
21Inventor score
Filing activity: Nov 19, 2018 → Nov 19, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US12049669B2 | Use of the IL-6 gene expression level for classification of a subject in risk groups in the prognosis or diagnosis of type II diabetes mellitus | Chemistry; Metallurgy | 0 | Active |
| US12203137B2 | Use of ADIPOQ gene expression level for classification of a subject in risk groups in the prognosis or diagnosis of type II diabetes mellitus | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.